Literature DB >> 23213088

Effect of patient socioeconomic status on access to early-phase cancer trials.

Aisyah Mohd Noor1, Debashis Sarker, Suzanne Vizor, Blair McLennan, Sarah Hunter, Aneta Suder, Henrik Moller, James F Spicer, Sophie Papa.   

Abstract

PURPOSE: Little is known about the influence of socioeconomic factors on patient access to cancer trials. Differences should be considered to ensure generalizability of trial results and equality of access.
METHODS: Phase I trials unit referrals at our center over 5 years, from 2007 to 2012, were reviewed. Socioeconomic status was defined by the Index of Multiple Deprivation (IMD; 1, least deprived; 5, most deprived). Multivariate analysis was performed comparing incident cancer cases with referred patients and those ultimately enrolled onto a trial.
RESULTS: Four hundred thirty patients were referred (median age, 62 years). Compared with 10,784 incident cases, referral was less likely for patients in the more-deprived quintiles compared with the least deprived (IMD 5: odds ratio [OR], 0.53; 95% CI, 0.38 to 0.74). Once reviewed in the unit, enrollment onto a trial was not affected (IMD 5: OR, 0.81; 95% CI, 0.40 to 1.63). Ethnicity analysis showed the nonwhite population was less likely to be recruited (OR, 0.48; 95% CI, 0.26 to 0.88). This relationship was lost with adjustment for age, sex, cancer type, and deprivation index.
CONCLUSION: We show for the first time to our knowledge that socioeconomic status affects early-phase cancer trial referrals. The least-deprived patients are almost twice as likely to be referred compared with the most deprived. This may be because more-deprived patients are less suitable for a trial-as a result of comorbidities, for example-or because of inequalities that could be addressed by patient or referrer education. Once reviewed at the unit, enrollment onto a trial is not affected by deprivation.

Entities:  

Mesh:

Year:  2012        PMID: 23213088     DOI: 10.1200/JCO.2012.45.0999

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

1.  Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.

Authors:  Tira Tan; Michael Rheaume; Lisa Wang; Helen Chow; Anna Spreafico; Aaron R Hansen; Albiruni R A Razak; Lillian L Siu; Philippe L Bedard
Journal:  Oncologist       Date:  2019-03-04

2.  The role of age on dose-limiting toxicities in phase I dose-escalation trials.

Authors:  A Schwandt; P J Harris; S Hunsberger; A Deleporte; G L Smith; D Vulih; B D Anderson; S P Ivy
Journal:  Clin Cancer Res       Date:  2014-07-15       Impact factor: 12.531

Review 3.  Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.

Authors:  Holly A Massett; Grace Mishkin; Larry Rubinstein; S Percy Ivy; Andrea Denicoff; Elizabeth Godwin; Kate DiPiazza; Jennifer Bolognese; James A Zwiebel; Jeffrey S Abrams
Journal:  Clin Cancer Res       Date:  2016-07-11       Impact factor: 12.531

4.  Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.

Authors:  Sarah B Garrett; Thea M Matthews; Corey M Abramson; Christopher J Koenig; Fay J Hlubocky; Christopher K Daugherty; Pamela N Munster; Daniel Dohan
Journal:  JCO Oncol Pract       Date:  2019-10-11

5.  Unequal cancer survivorship care: addressing cultural and sociodemographic disparities in the clinic.

Authors:  Antonella Surbone; Michael T Halpern
Journal:  Support Care Cancer       Date:  2016-10-06       Impact factor: 3.603

6.  The impact of socioeconomic status on melanoma clinical trial participation: an observational cohort study from Australia.

Authors:  Joshua L Lee; Lauren E Haydu; John F Thompson; Rachael L Morton
Journal:  Melanoma Manag       Date:  2014-12-04

7.  Male Breast Cancer: A Comparative Analysis from the National Cancer Database.

Authors:  Elizabeth B Elimimian; Leah Elson; Hong Li; Hong Liang; Nadeem Bilani; Emily C Zabor; Abby Statler; Zeina Nahleh
Journal:  World J Mens Health       Date:  2020-12-04       Impact factor: 5.400

8.  Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study.

Authors:  C Baldini; E Charton; E Schultz; L Auroy; A Italiano; M Robert; E Coquan; N Isambert; P Moreau; S Le Gouill; C Le Tourneau; Z Ghrieb; J J Kiladjian; J P Delord; C Gomez Roca; N Vey; F Barlesi; T Lesimple; N Penel; J C Soria; C Massard; S Besle
Journal:  ESMO Open       Date:  2022-05-06

9.  Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.

Authors:  Jessica Rearden; Alexandra L Hanlon; Connie Ulrich; Margo Brooks-Carthon; Marilyn Sommers
Journal:  Oncol Nurs Forum       Date:  2016-01       Impact factor: 2.172

Review 10.  The impact of socioeconomic status on access to cancer clinical trials.

Authors:  K Sharrocks; J Spicer; D R Camidge; S Papa
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.